Holen Sie sich die Stockscreener-App
13.71
0.81%
0.11
Handel nachbörslich:
13.74
0.03
+0.22%
Schlusskurs vom Vortag:
$13.60
Offen:
$14.13
24-Stunden-Volumen:
14.33M
Relative Volume:
1.32
Marktkapitalisierung:
$4.08B
Einnahmen:
$8.22B
Nettoeinkommen (Verlust:
$28.95M
KGV:
-228.50
EPS:
-0.06
Netto-Cashflow:
$901.06M
1W Leistung:
+9.59%
1M Leistung:
-22.37%
6M Leistung:
-8.48%
1J Leistung:
-0.36%
1-Tages-Spanne:
$13.39
$14.57
1-Wochen-Bereich:
$11.85
$14.57
52-Wochen-Spanne:
$11.20
$23.80
Oscar Health Inc Stock (OSCR) Company Profile
Firmenname
Oscar Health Inc
Sektor
Branche
Telefon
(646) 403-3677
Adresse
75 VARICK STREET, NEW YORK
Compare OSCR vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OSCR
Oscar Health Inc
|
13.71 | 4.05B | 8.22B | 28.95M | 901.06M | -0.06 |
|
UNH
Unitedhealth Group Inc
|
284.37 | 252.65B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
77.93 | 97.99B | 402.11B | 1.73B | 7.81B | 1.3789 |
|
CI
Cigna Group
|
287.61 | 77.65B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
336.04 | 72.89B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
178.83 | 21.10B | 126.36B | 1.30B | 1.55B | 10.67 |
Oscar Health Inc Stock (OSCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | UBS | Sell → Neutral |
| 2026-01-05 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-12-11 | Eingeleitet | Stephens | Equal-Weight |
| 2025-11-26 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-25 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-07-15 | Herabstufung | UBS | Neutral → Sell |
| 2025-07-14 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-07-11 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2025-07-02 | Eingeleitet | Barclays | Underweight |
| 2025-06-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-10 | Eingeleitet | Jefferies | Underperform |
| 2024-11-06 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-10-07 | Eingeleitet | UBS | Neutral |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-22 | Eingeleitet | Raymond James | Outperform |
| 2023-11-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-06-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-11-16 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-06-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-14 | Herabstufung | Goldman | Neutral → Sell |
| 2022-01-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-14 | Eingeleitet | Goldman | Sell |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-03-30 | Eingeleitet | Wells Fargo | Overweight |
| 2021-03-29 | Eingeleitet | BofA Securities | Buy |
| 2021-03-29 | Eingeleitet | Cowen | Market Perform |
| 2021-03-29 | Eingeleitet | Credit Suisse | Outperform |
| 2021-03-29 | Eingeleitet | Goldman | Buy |
| 2021-03-29 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Oscar Health Inc Aktie (OSCR) Neueste Nachrichten
Raymond James upgrades Oscar Health on valuation and margin recovery outlook - Investing.com Canada
Raymond James Upgrade Boosts Oscar Health Stock After Q4 Earnings - Benzinga
Raymond James Upgrades Oscar Health to Outperform From Market Perform, Price Target is $18 - marketscreener.com
New Forecasts: Here's What Analysts Think The Future Holds For Oscar Health, Inc. (NYSE:OSCR) - simplywall.st
Raymond James upgrades Oscar Health stock rating to Outperform By Investing.com - Investing.com South Africa
Raymond James upgrades Oscar Health stock rating to Outperform - Investing.com
Oscar Health Stock Gains: Key Insights - Intellectia AI
Oscar Health, Inc. (OSCR) Upgraded as Valuation Appears Balanced - Finviz
Oscar Health, Inc. (OSCR) upgraded as valuation appears balanced - MSN
Oscar Health projects 2026 revenue of up to $19B, membership reaches 3.4 million - Traders Union
Is Oscar Health (OSCR) one of the under-the-radar AI stocks to buy? - MSN
Is Oscar Health (OSCR) One of the Under-the-Radar AI Stocks to Buy? - Insider Monkey
Oscar Health Q4: Tricky 2025, Promising 2026Long-Term Bull Thesis Attractive (OSCR) - Seeking Alpha
Oscar Health, Inc. (NYSE:OSCR) Q4 2025 earnings call transcript - MSN
Oscar Health, Inc. (NYSE:OSCR) Q4 2025 Earnings Call Transcript - Insider Monkey
CVS, Oscar Health report diverging 2025 results - Insurance Business
Why Oscar Health (OSCR) Is Down 7.4% After Wider 2025 Losses But Confident 2026 Profit Outlook - Yahoo Finance
Oscar Health Q4 Earnings Call Highlights - MarketBeat
Oscar Health (OSCR) Sets Ambitious 2026 Revenue Outlook Amid Cha - GuruFocus
Oscar Health (OSCR) Projects Significant FY26 Earnings Growth - GuruFocus
Oscar Health Reports Optimistic Guidance Boosting Stock - Intellectia AI
Why Oscar Health Stock Ticked up on Tuesday - Yahoo Finance
Why Oscar Health Stock Ticked up on Tuesday - The Motley Fool
Oscar Health Charts Risky Path Toward 2026 Profitability - TipRanks
Schwab & Stifel fall, Paramount sweetens WBD bid, Oscar Health earnings - Yahoo Finance
House panel subpoenas 8 health insurers - The Hill
Oscar Health Inc (OSCR) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Outlook ... By GuruFocus - Investing.com Canada
Oscar Health gains as outlook tops consensus despite Obamacare headwinds - Seeking Alpha
Oscar Health Bets On 2026 Profit Turnaround After Tough 2025Oscar Health (NYSE:OSCR) - Benzinga
Oscar Health (OSCR) Reports Strong Revenue Growth and Market Sha - GuruFocus
Oscar Health OSCR Q4 2025 Earnings Call Transcript - AOL.com
Oscar Health (OSCR) Stock Trades Up, Here Is Why - Finviz
Oscar Health Stock Surges on Upbeat 2026 Revenue GuidanceNews and Statistics - IndexBox
Oscar Health (NYSE:OSCR) Shares Gap UpHere's What Happened - MarketBeat
Oscar Health (OSCR) Reports Lower Q4 Revenue, Aims for Profitabi - GuruFocus
Oscar Health stock drops after Q4 results fall short despite upbeat 2026 guidance - MSN
Earnings call transcript: Oscar Health Q4 2025 misses EPS and revenue forecasts By Investing.com - Investing.com India
Earnings call transcript: Oscar Health Q4 2025 misses EPS and revenue forecasts - Investing.com
Oscar Health (OSCR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Oscar Health reports Q4 EPS ($1.24), consensus (92c) - TipRanks
Oscar Health (NYSE:OSCR) Posts Quarterly Earnings Results, Misses Estimates By $0.40 EPS - MarketBeat
Oscar Health (NYSE:OSCR) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings - Finviz
Why Is OSCR Stock Rising Today? - Stocktwits
Oscar Health Revenue Rises, Eyes Profitability This Year - The Wall Street Journal
Oscar Health Inc (NYSE:OSCR) Posts Wider Q4 Loss on Surging Medical Costs, Shares Drop - ChartMill
Oscar Health Reports Record Membership and 2026 Financial Outlook - Intellectia AI
Oscar Health (OSCR) Misses Q4 Earnings and Revenue Estimates - GuruFocus
Oscar Health, Inc. (OSCR) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Oscar Health stock rises in premarket after 2026 revenue outlook; House subpoenas add a fresh risk - TechStock²
Oscar Health Q4 Loss Widens, Revenue Rises - marketscreener.com
Oscar Health Inc enters $475 million revolving credit facility on Feb 6SEC filing - marketscreener.com
Finanzdaten der Oscar Health Inc-Aktie (OSCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
3.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):